Samuel J. Reich - CEO & EXECUTIVE CHAIRMAN, Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & EXECUTIVE CHAIRMAN, Director
Stock Symbol
SABS, SABSW on Nasdaq
All Insider Reports
All Insider Reports

Samuel J. Reich - trading volume in the past year for SAB Biotherapeutics, Inc.

Holdings reported by Samuel J. Reich for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 548K $482K $0.88 Nov 29, 2023 Via Big Cypress Holdings LLC
Common Stock 219K $193K $0.88 Nov 29, 2023 Direct
Stock Option (right to buy) 35.7K Jul 15, 2024 Direct Common Stock

Transactions reported by Samuel J. Reich for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.